Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11

Showing 11 citing articles:

The role of cancer-associated fibroblasts and exosomal miRNAs-mediated intercellular communication in the tumor microenvironment and the biology of carcinogenesis: a systematic review
Reza Nedaeinia, Simin Najafgholian, Rasoul Salehi, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance
Zhi Liu, Chunyu Zhang, Jiatong Xiao, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1966-1986
Open Access
Focus on mechano-immunology: new direction in cancer treatment
Lin Zhao, Yajun Gui, Xiangying Deng
International Journal of Surgery (2025) Vol. 111, Iss. 3, pp. 2590-2602
Open Access
Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies
Monika Granica, Gustaw Laskowski, Paweł Link-Lenczowski, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189274-189274
Open Access
EBF1-induced CSRP2 boosts the progression of B-cell acute lymphocytic leukemia by inhibiting ferroptosis
Chengcheng Liu, Gexiu Liu, Fenling Zhou, et al.
Cancer Letters (2025) Vol. 614, pp. 217556-217556
Closed Access
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
The multifaceted role of phosphodiesterase 4 in tumor: from tumorigenesis to immunotherapy
Huimin Ren, Shaohui Zhang, Peiyuan Li
Frontiers in Immunology (2025) Vol. 16
Open Access
Comparable Survival Outcomes in HLA-Matched and Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Patients Aged 40-50: A CBMTR Registry-Based Propensity Score Matching Analysis Over the Last Decade
Zhengli Xu, Yuping Zhang, Baodong Ye, et al.
Cancer Letters (2025), pp. 217594-217594
Closed Access
MEF2A is a transcription factor for circPVT1 and contributes to the malignancy of acute myeloid leukemia
Kun Wu, Yuntao Li, Bo Nie, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 5
Closed Access | Times Cited: 1
Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial cells in guidance of specifying the field cancerized surgical excision margin and administering immunotherapy
Zhengzheng Fu, Lína Zhang, Rongyi Chen, et al.
Cancer Letters (2024) Vol. 598, pp. 217099-217099
Open Access
PD-L1 upregulation in activated fibroblasts promotes silica particle-induced pulmonary fibrosis
Youliang Zhao, Yaqian Qu, Meixiu Duan, et al.
International Journal of Biological Macromolecules (2024) Vol. 291, pp. 139147-139147
Closed Access
Page 1

Scroll to top